New York Life Investment Management LLC Cullinan Oncology, Inc. Transaction History

New York Life Investment Management LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 03, 2024	SELL	$10.17 - $19.02 $127,216 - $237,921	-12,509 Reduced 37.05%	21,250 $362,000
Q4 2023 Feb 05, 2024	SELL	$7.89 - $10.23 $8,245 - $10,690	-1,045 Reduced 3.0%	33,759 $344,000
Q3 2023 Nov 07, 2023	SELL	$9.05 - $11.72 $49,621 - $64,260	-5,483 Reduced 13.61%	34,804 $314,000
Q2 2023 Aug 04, 2023	SELL	$8.8 - $13.4 $31,838 - $48,481	-3,618 Reduced 8.24%	40,287 $433,000
Q1 2023 May 08, 2023	BUY	$10.2 - $11.91 $447,830 - $522,908	43,905 New	43,905 $449,000

146

67.6M

612K

118K

Ticker CGEM
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 45,612,200
Market Cap $499M
Description
Cullinan Oncology Inc., a biopharmaceutical company, focuses on developing a pipeline of targeted oncology and immuno-oncology therapies for cancer patients in the United States. The company's lead candidate is the CLN-081, an orally available small molecule that is in a Phase I/IIa dose escalation and expansion trial for treating patients with ...

Get notified when there are updates to the investment portfolio of New York Life Investment Management LLC, based on Form 13F filings with the SEC.

Stay updated on New York Life Investment Management LLC with notifications on news.